05 Compliance

Where magnesium L-threonate is permitted, and what the file must show

Technical document 05 · Reviewed 2026-11-18 · Magnesium L-Threonate

On this page
  1. Four checks, one file
  2. European Union and the United Kingdom
  3. United States
  4. Contaminants and microbiology
  5. The claims boundary
  6. The document set
  7. Before the file is called complete

In the European Union and Great Britain, magnesium L-threonate is a listed magnesium source for food supplements; in the United States, the file must establish the dietary-ingredient basis for the exact form. Permission is only the first check. The salt carries a novel-food history, a daily magnesium figure, a labelling condition and a contaminant panel, and each one has to be shown in the file.

In one line

Permitted status is form-specific: the EU, US and UK each ask for their own basis, and the file must show the exact salt, the dose and the label wording.

Four checks, one file

The file answers four separate questions. Is this exact salt a permitted source in this market? What daily amount and population does the permission cover? What must the label say? And which contaminant, microbiological and claim limits apply to the finished product?

A certificate supports identity and purity, but the permission, the dose and the label are product-level facts. The file is complete when the four answers point to the same salt, use level and finished product.

European Union and the United Kingdom

Magnesium L-threonate was authorised as a novel food by Commission Implementing Regulation (EU) 2024/2694. The authorisation covers food supplements for adults, excluding pregnant and lactating women, at a maximum of 250 mg magnesium a day, corresponding to about 3,000 mg magnesium L-threonate. The label has to name “Magnesium L-threonate” and carry the adult-only statement excluding pregnant and lactating women.

Commission Regulation (EU) 2025/2225 then added magnesium L-threonate to Annex II to Directive 2002/46/EC as a permitted magnesium source. The two instruments do different jobs: the novel-food authorisation sets the conditions of use and labelling; the Annex II entry makes the salt a permitted form. The file should cite both. As of this review, the consolidated text is the reference; a label printed years ago is not evidence of current status.

The EU novel-food specification uses L-threonic acid at not less than 85% and magnesium at 7.2–8.3%. That is not the same line as a 98.0–102.0% salt assay; if the file quotes the novel-food specification, the COA has to carry that figure or the calculation that connects the two. The COA page sets out the difference between the salt assay and the elemental figure.

Great Britain maintains its own nutrition and novel-food lists. As of this review, England, Scotland and Wales have each added magnesium L-threonate monohydrate to the substances permitted in food supplements during 2026, with purity criteria set alongside. Northern Ireland continues to apply the EU novel-food list. The UK file therefore needs the instrument for the relevant nation, the purity criteria and the novel-food authorisation.

The GB permission is built on the monohydrate, and the purity criteria are specific to that form. A certificate that names “magnesium L-threonate” without a hydrate state does not show which form the lot is. That is a specification point before it is a labelling point, and it is the reason the identity page regards the hydrate state as part of the salt’s identity.

United States

A magnesium L-threonate supplement is regulated as a dietary supplement. The legal basis is that the ingredient is lawful for its intended use. That basis can be a GRAS notice, a new dietary ingredient notification, or another documented conclusion, and it is specific to the form and the use level.

A public GRAS notice exists for magnesium L-threonate hydrate (GRN 499), with a no-questions letter from the FDA. A notice is tied to the notifier’s material and intended use; it is not a blanket approval of every hydrate or use level. The US file should state the basis in one sentence and attach the document, with the form and the notification number where one applies.

On the label, the Supplement Facts panel declares elemental magnesium, while the ingredient list names the salt. A structure/function statement must be truthful and not deceptive, must not be a disease claim, and carries the required disclaimer.

Contaminants and microbiology

Contaminant limits · EU food-supplement ceilings and catalog release limits
ParameterEU food-supplement limitCatalog release limit
Lead (Pb)3.0 mg/kg≤3 mg/kg
Cadmium (Cd)1.0 mg/kg≤1 mg/kg
Mercury (Hg)0.10 mg/kg≤0.1 mg/kg
Arsenic (As)No harmonised EU maximum for supplements≤2 mg/kg
Aerobic plate countSet by specification and process≤1,000 cfu/g
Yeast and mouldSet by specification and process≤100 cfu/g
E. coliAbsence in the specificationAbsent
SalmonellaAbsence in the specificationAbsent

The EU limits come from Regulation (EU) 2023/915 and apply to the food supplement as placed on the market. A raw material released at the ceiling leaves no room for the formula; a tighter purchase limit is the buyer’s choice. Arsenic has no harmonised EU maximum for supplements, so the 2 mg/kg figure is a specification choice, not an EU number.

The claims boundary

In the EU, magnesium claims are authorised by Regulation (EU) 432/2012 and are subject to the condition that the product provides at least 15% of the nutrient reference value per portion. The magnesium salt named on the label can carry a magnesium claim; the L-threonate part does not add an authorised claim of its own. Great Britain applies the retained magnesium claims list in the same way.

In the US, a structure/function statement is allowed without pre-approval, provided it is truthful, not deceptive and not a disease claim, and provided the disclaimer is present. A statement about the salt’s identity is not a claim; a statement about what the salt does in the body is. The file should separate the two, and the label should carry only the wording the market allows.

The document set

  • Batch COA with the salt assay, magnesium, identity, loss on drying, pH, mesh, metals and microbiology.
  • Product specification with the hydrate state and the test methods.
  • Technical data sheet and safety data sheet.
  • EU novel-food and Annex II statement, with the current citations.
  • US dietary-ingredient basis: the GRAS notice or the notification, with the form and use level.
  • UK instrument and purity-criteria statement for the relevant nation.
  • Allergen, non-GMO and country-of-origin statements.
  • Retained-sample and lot-traceability record.

Before the file is called complete

  • The label names the exact salt and, for the UK, the monohydrate.
  • The daily magnesium from the salt is inside the authorised figure.
  • The adult-only statement and the pregnancy and lactation exclusion are present where required.
  • The contaminant limits leave margin for the finished formula.
  • Every claim is from the authorised list, or is a structure/function statement with the disclaimer.
  • The COA lot number matches the pack, the retained sample and the market file.
  • The citations are the current texts, not a previous consolidation.

The market notes for the European Union, United States and United Kingdom carry the instruments and the reading list. The product page carries the specification, and the Annex II note explains what a positive-list entry does and does not cover.

Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.

Request a quotation